Innovation drought?

Beneath Americaâ??s financial woes lies a lack of innovation, a recent BusinessWeek
article
argues. A paucity of breakthrough products could have triggered the nationâ??s borrowing binge and ultimately the
financial meltdown, it says.

Hereâ??s the logic: A decade ago, the nation was enamored with scientific and technological breakthroughs. Gene therapy would
cure physical ailments, fuel cells would power cars, and satellites would extend high-speed Internet to rural areas. Today,
despite massive investment in the technologies, few new products have materialized.

As a result, wages stagnated. Also, exports slowed and imports surged, which forced Americans to borrow from overseas sources.
The misplaced optimism played into Wall Street excesses.

Close to home, the innovation problem is on clear display at Eli Lilly and Co., which is hustling to find something big to
replace patents on top-selling drugs including Zyprexa. Lilly stock, which stands near $34, is nowhere near the $80-plus where
it traded early this decade.

BusinessWeek predicts the investment ultimately will lead to those long-expected breakthrough products. For now, lots of people
are frustrated and the economy is still sluggish.

What are your thoughts?

Please enable JavaScript to view this content.

Editor's note: IBJ is now using a new comment system. Your Disqus account will no longer work on the IBJ site. Instead, you can leave a comment on stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Past comments are not currently showing up on stories, but they will be added in the coming weeks. Please note our updated comment policy that will govern how comments are moderated.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}